SK282360B6 - Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie - Google Patents

Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie Download PDF

Info

Publication number
SK282360B6
SK282360B6 SK3879-91A SK387991A SK282360B6 SK 282360 B6 SK282360 B6 SK 282360B6 SK 387991 A SK387991 A SK 387991A SK 282360 B6 SK282360 B6 SK 282360B6
Authority
SK
Slovakia
Prior art keywords
asn
insulin
peptide
tyr
cys
Prior art date
Application number
SK3879-91A
Other languages
English (en)
Slovak (sk)
Inventor
Stefan M�Llner
Wolfgang K�Nig
Gnter Mller
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of SK282360B6 publication Critical patent/SK282360B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK3879-91A 1990-12-19 1991-12-18 Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie SK282360B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4040574 1990-12-19

Publications (1)

Publication Number Publication Date
SK282360B6 true SK282360B6 (sk) 2002-01-07

Family

ID=6420676

Family Applications (2)

Application Number Title Priority Date Filing Date
SK3879-91A SK282360B6 (sk) 1990-12-19 1991-12-18 Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie
SK232-2001A SK282361B6 (sk) 1990-12-19 1991-12-18 Farmaceutický prostriedok na diabetes mellitus

Family Applications After (1)

Application Number Title Priority Date Filing Date
SK232-2001A SK282361B6 (sk) 1990-12-19 1991-12-18 Farmaceutický prostriedok na diabetes mellitus

Country Status (24)

Country Link
US (1) US5461035A (fr)
EP (1) EP0491361B1 (fr)
JP (2) JP3378588B2 (fr)
KR (1) KR100237948B1 (fr)
AT (1) ATE177753T1 (fr)
AU (1) AU643349B2 (fr)
CA (1) CA2058020C (fr)
CZ (1) CZ284568B6 (fr)
DE (1) DE59109109D1 (fr)
DK (1) DK0491361T3 (fr)
ES (1) ES2130130T3 (fr)
FI (1) FI105816B (fr)
GR (1) GR3030510T3 (fr)
HR (1) HRP940839B1 (fr)
HU (1) HU222493B1 (fr)
IE (1) IE914408A1 (fr)
IL (1) IL100400A (fr)
NO (1) NO308951B1 (fr)
NZ (1) NZ241029A (fr)
PT (1) PT99850B (fr)
SK (2) SK282360B6 (fr)
TW (1) TW227004B (fr)
YU (1) YU189891A (fr)
ZA (1) ZA919938B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE184611T1 (de) * 1991-11-29 1999-10-15 Hoechst Ag Peptide mit insulinartiger wirkung
SE0002716L (sv) * 2000-07-18 2002-01-19 Lars Wahlberg Komposition mot insekter
CN100354118C (zh) * 2001-01-15 2007-12-12 米其林技术公司 轮胎成型鼓
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
KR101909052B1 (ko) * 2017-02-09 2018-10-17 강원대학교산학협력단 인슐린의 a 사슬로부터 유래된 펩타이드 단편 및 이를 포함하는 당뇨병 또는 당뇨병성 창상의 예방 또는 치료용 약학 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2740406A1 (de) * 1977-09-08 1979-03-22 Hoechst Ag Teilgeschuetzte human-insulin-a-kette und verfahren zu ihrer herstellung
DE2801175A1 (de) * 1978-01-12 1979-07-19 Hoechst Ag Verfahren zur herstellung cysteinhaltiger peptide
DD147942A1 (de) * 1979-08-20 1981-04-29 Guenter Losse Verfahren zur herstellung von cystin-peptiden mit insulinaehnlicher wirkung
FR2525592B1 (fr) * 1982-04-26 1984-09-14 Pasteur Institut

Also Published As

Publication number Publication date
JPH04295496A (ja) 1992-10-20
NO914999L (no) 1992-06-22
CS387991A3 (en) 1992-07-15
YU189891A (sh) 1995-10-03
KR920012115A (ko) 1992-07-25
ATE177753T1 (de) 1999-04-15
GR3030510T3 (en) 1999-10-29
HU222493B1 (hu) 2003-07-28
DE59109109D1 (de) 1999-04-22
NO914999D0 (no) 1991-12-18
ZA919938B (en) 1992-09-30
FI915933A (fi) 1992-06-20
HU914009D0 (en) 1992-03-30
JP3378588B2 (ja) 2003-02-17
PT99850A (pt) 1992-11-30
US5461035A (en) 1995-10-24
FI915933A0 (fi) 1991-12-17
IL100400A (en) 1998-01-04
IL100400A0 (en) 1992-09-06
JP3802863B2 (ja) 2006-07-26
FI105816B (fi) 2000-10-13
HRP940839A2 (en) 1997-06-30
CA2058020C (fr) 2003-10-28
EP0491361B1 (fr) 1999-03-17
AU8982591A (en) 1992-06-25
HUT59697A (en) 1992-06-29
DK0491361T3 (da) 1999-10-11
EP0491361A2 (fr) 1992-06-24
NO308951B1 (no) 2000-11-20
IE914408A1 (en) 1992-07-01
AU643349B2 (en) 1993-11-11
CA2058020A1 (fr) 1992-06-20
KR100237948B1 (ko) 2000-01-15
JP2003176237A (ja) 2003-06-24
TW227004B (fr) 1994-07-21
EP0491361A3 (en) 1993-11-24
PT99850B (pt) 1999-06-30
HRP940839B1 (en) 2000-02-29
ES2130130T3 (es) 1999-07-01
CZ284568B6 (cs) 1999-01-13
NZ241029A (en) 1993-01-27
SK282361B6 (sk) 2002-01-07

Similar Documents

Publication Publication Date Title
FI79854C (fi) Foerfarande foer framstaellning av ett laekemedelspreparat som innehaoller ett insulinderivat.
JP3445269B2 (ja) インスリン様成長因子およびアナログの適用による網膜ニューロン障害の治療
US5861379A (en) Chimeric fatty body-pro-GRF analogs with increased biological potency
US5847066A (en) Analogs of growth hormone-releasing factor
AU636301B2 (en) Cyclic grf-analogs ii
JPH0314599A (ja) ペプチド誘導体類
NO315611B1 (no) Forbindelser med veksthormonfrigjörende egenskaper, farmasöytiske preparater som omfatter dem, samt anvendelse derav til fremstilling avmedikamenter
DK164408B (da) Vaeksthormonfrigivende faktorforbindelser, forbindelserne til anvendelse som terapeutikum, fremgangsmaade til fremstilling af forbindelserne, farmaceutiske praeparater, der indeholder en effektiv maengde af en saadan forbindelse samt anvendelse af forbindelsen
US4992417A (en) Superactive human insulin analogues
EP0044168B1 (fr) Peptides en tant que médicaments, et certains peptides
FI98731C (fi) Menetelmä superaktiivisten insuliinianalogien valmistamiseksi
EP0526192B1 (fr) Hexapeptide
JPH09506616A (ja) 拮抗活性を有するｈＧＨ−ＲＨ（１−２９）ＮＨ▲下２▼の類似体
CS251085B2 (en) Method of peptides production liberating growth hormone
SK282360B6 (sk) Peptidy, spôsob ich výroby, farmaceutický prostriedok tieto látky obsahujúci a ich použitie
US5622934A (en) Peptides with an insulin-like action
JPH01199997A (ja) 哺乳動物の脳下垂体に作用するペプチド
WO1989007113A1 (fr) Analogues de facteurs de liberation de l'hormone de croissance
HU201566B (en) Process for producing new analoguse of activatin factor of human growth hormon and pharmaceutical and veterinair compositions containing them

Legal Events

Date Code Title Description
MK4A Patent expired

Expiry date: 20111218